COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,536 Articles (22,881 medRxiv, 8,655 bioRxiv)

Most recent first Previous |  Page 1487: Articles 14861-14870  | Next

A clinical observational analysis of aerosol emissions from dental procedures.
Dudding, T., Sheikh, S., Gregson, F., Haworth, J., Haworth, S., Main, B., Shrimpton, A., Hamilton, F., Ireland, T., Maskell, N., Reid, J., Bzdek, B., Gormley, M. J.
10.1101/2021.06.09.21258479 — Posted: 2021-06-12
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent Covid-19 -- a prospective multicentre cohort study
Kohler, P., Guesewell, S., Seneghini, M., Egger, T., Leal-Neto, O., Brucher, A., Lemmenmaier, E., Moeller, C., Rieder, P., Ruetti, M., Stocker, R., Vuichard-Gysin, D., Wiggli, B., Besold, U., Friedl, A., Kuster, S., McGeer, A., Risch, L., Schlegel, M., Vernazza, P., Kahlert, C. R.
10.1101/2021.06.09.21258422 — Posted: 2021-06-12
COVID-19 antibody detection and assay performance using red cell agglutination
Srivastava, K., West, K. A., De Giorgi, V., Holbrook, M. R., Bovin, N. V., Henry, S. M., Flegel, W. A.
10.1101/2021.06.09.21258232 — Posted: 2021-06-12
A novel strategy for the detection of SARS-CoV-2 variants based on multiplex PCR-MALDI-TOF MS
Zhao, F., Zhang, J., Wang, X., Hou, X., Qin, T., Meng, F., Xu, X., Li, T., Zhou, H., Kan, B., Lu, J., Xiao, D.
10.1101/2021.06.08.21258523 — Posted: 2021-06-12
NEWS-2 score assessment of inpatient referral during the COVID 19 epidemic
FAURE, V., SOURIS, M., WILMET, A., BAUDINO, F., BRIZIO, A., MALHAIRE, C., PECCAUD, F.-X., GONZALEZ, J.-P.
10.1101/2021.06.10.21254528 — Posted: 2021-06-12
The impact of co-circulating pathogens on SARS-CoV-2/COVID-19 surveillance. How concurrent epidemics may decrease true SARS-CoV-2 percent positivity.
Kovacevic, A., Eggo, R. M., Baguelin, M., Domenech de Celles, M., Opatowski, L.
10.1101/2021.06.08.21258533 — Posted: 2021-06-12
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Proteinco-immunization in rhesus macaques
Rosati, M., Agarwal, M., Hu, X., Devasundaram, S., Stellas, D., Chowdhury, B., Bear, J., Burns, R., Donohue, D., Pessaint, L., Andersen, H., Lewis, M. G., Terpos, E., Dimopoulos, M. A., Wlodawer, A., Mullins, J. I., Venzon, D. J., Pavlakis, G. N., Felber, B. K.
10.1101/2021.06.11.448032 — Posted: 2021-06-11
A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants
Haslwanter, D., Dieterle, M. E., Wec, A. Z., O'Brien, C. M., Sakharkar, M., Florez, C., Tong, K., Rappazzo, C. G., Lasso, G., Vergnolle, O., Wirchnianski, A. S., Bortz, R. H., Laudermilch, E., Fels, J. M., Mengotto, A., Malonis, R. J., Georgiev, G. I., Quiroz, J., Wrapp, D., Wang, N., Dye, K. E., Barnhill, J., Dye, J. M., McLellan, J. S., Daily, J. P., Lai, J. R., Herbert, A. S., Walker, L., Chandran, K., Jangra, R. K.
10.1101/2021.06.10.447999 — Posted: 2021-06-11
B.1.1.7 and B.1.351 SARS-CoV-2 variants display enhanced Spike-mediated fusion
Rajah, M. M., Hubert, M., Bishop, E., Saunders, N., Robinot, R., Grzelak, L., Planas, D., Zivaljic, M., Planchais, C., Guivel-Benhassine, F., Porrot, F., Mouquet, H., Chakrabarti, L., Buchrieser, J., Schwartz, O.
10.1101/2021.06.11.448011 — Posted: 2021-06-11
Anti-SARS-CoV-2 hyperimmune immunoglobulin provides potent and robust neutralization capacity and antibody-dependent cellular cytotoxicity and phagocytosis induction through N and S proteins
Diez, J.-M., Romero, C., Cruz, M., Vandeberg, P., Merritt, W. K., Pradenas, E., Trinite, B., Blanco, J., Clotet, B., Willis, T., Gajardo, R.
10.1101/2021.06.11.447942 — Posted: 2021-06-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).